Oncolytics Biotech (ONCY -1.5%) dips after closing out its previously announced underwritten public offering of 8M shares at $4. The company intends to use the net proceeds from the offering to fund its clinical trial and manufacturing program.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Feb 11, 2015)
at Benzinga.com (Dec 22, 2014)
at Fox Business (Sep 9, 2013)
at MarketWatch.com (Sep 12, 2012)
at CNBC.com (Sep 12, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs